Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

City’s largest share sale in four years shows Beijing’s determination to push China’s EV technologies worldwide, analysts say ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

The underwriters on Hengrui Pharmaceutical Hong Kong listing are represented by Herbert Smith Freehills and Jingtian & ...

Pony AI Inc has confidentially filed for Hong Kong IPO to raise capital for expansion. Its stock surged and caught fire for ...

Robinhood rival EToro Group raised nearly $620 million in its IPO. Meanwhile, Ryan Reynolds's MNTN is considering launching ...

Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a regulatory filing made on Thursday.